AdaptHealth Capital Expenditures (CapEx) Growth & History (AHCO)
AdaptHealth's capital expenditures (capex) was $382.4M for fiscal 2025.
View full AdaptHealth company overviewAdaptHealth annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $382.4M | $76.3M | +24.94% |
| 2024 | 2024-12-31 | $306.1M | −$31.4M | −9.31% |
| 2023 | 2023-12-31 | $337.5M | −$54.0M | −13.79% |
| 2022 | 2022-12-31 | $391.4M | $188.1M | +92.53% |
| 2021 | 2021-12-31 | $203.3M | $163.6M | +411.40% |
| 2020 | 2020-12-31 | $39.8M | $18.4M | +86.36% |
| 2019 | 2019-12-31 | $21.3M | $11.4M | +114.39% |
| 2018 | 2018-12-31 | $9.9M | — | — |
AdaptHealth quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $166.2M | $77.6M | +87.50% |
| Q1 2026 | 2026-03-31 | $121.2M | $25.6M | +26.81% |
| Q4 2025 | 2025-12-31 | $103.9M | $26.6M | +34.34% |
| Q3 2025 | 2025-09-30 | $94.2M | $34.7M | +58.24% |
| Q2 2025 | 2025-06-30 | $88.7M | $7.4M | +9.10% |
| Q1 2025 | 2025-03-31 | $95.6M | $7.7M | +8.75% |
| Q4 2024 | 2024-12-31 | $77.3M | −$11.3M | −12.76% |
| Q3 2024 | 2024-09-30 | $59.6M | −$17.5M | −22.74% |
| Q2 2024 | 2024-06-30 | $81.3M | −$1.3M | −1.62% |
| Q1 2024 | 2024-03-31 | $87.9M | −$1.2M | −1.38% |
| Q4 2023 | 2023-12-31 | $88.6M | −$54.3M | −37.97% |
| Q3 2023 | 2023-09-30 | $77.1M | −$17.1M | −18.14% |
| Q2 2023 | 2023-06-30 | $82.6M | $5.4M | +7.04% |
| Q1 2023 | 2023-03-31 | $89.1M | $12.0M | +15.49% |
| Q4 2022 | 2022-12-31 | $142.9M | $79.3M | +124.63% |
| Q3 2022 | 2022-09-30 | $94.2M | $33.9M | +56.20% |
| Q2 2022 | 2022-06-30 | $77.2M | $33.4M | +76.20% |
| Q1 2022 | 2022-03-31 | $77.2M | $41.6M | +116.78% |
| Q4 2021 | 2021-12-31 | $63.6M | $46.7M | +275.99% |
| Q3 2021 | 2021-09-30 | $60.3M | $48.4M | +405.83% |
| Q2 2021 | 2021-06-30 | $43.8M | $40.4M | +1195.47% |
| Q1 2021 | 2021-03-31 | $35.6M | $28.1M | +372.47% |
| Q4 2020 | 2020-12-31 | $16.9M | $10.0M | +145.98% |
| Q3 2020 | 2020-09-30 | $11.9M | $8.2M | +221.09% |
| Q2 2020 | 2020-06-30 | $3.4M | −$2.1M | −37.88% |
| Q1 2020 | 2020-03-31 | $7.5M | $2.2M | +42.21% |
| Q4 2019 | 2019-12-31 | $6.9M | — | — |
| Q3 2019 | 2019-09-30 | $3.7M | — | — |
| Q2 2019 | 2019-06-30 | $5.4M | — | — |
| Q1 2019 | 2019-03-31 | $5.3M | — | — |
AdaptHealth capital expenditures (capex) trends
Over the last five fiscal years, AdaptHealth's capital expenditures (capex) increased from $39.8M to $382.4M, a change of $342.6M. The latest reported quarter, Q2 2026, shows $166.2M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AdaptHealth source filings ↗